Dyadic to present at h.c. wainwright global investment conference

Jupiter, fla., may 20, 2022 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai) a global biotechnology company focused on further improving, applying and deploying its proprietary c1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the company will participate in the 2022 h.c. wainwright global investment conference at the fontainebleau miami beach hotel in miami florida. the hybrid conference will take place may 23rd - 26th, 2022. dyadic 's president and ceo, mark emalfarb will be presenting on wednesday, may 25, 2022, at 12:30 pm et.
DYAI Ratings Summary
DYAI Quant Ranking